Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b studyLai Wei, Zhongping Duan, Qin Ning et al.|Hepatology International|2018Cited by 22
Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks PosttreatmentChun Jen Liu, Pei‐Jer Chen, I‐Shyan Sheen et al.|Clinical Infectious Diseases|2021Cited by 11